Off-label low dose amitriptyline for insomnia disorder: Patient-reported outcomes

Area of Science:

• Sleep Medicine
• Pharmacology
• Clinical Psychiatry

Background:

• Low-dose amitriptyline is frequently used off-label for sleep maintenance issues in insomnia disorder.
• Limited data exist on real-world treatment outcomes for this indication.
• Patient-reported outcomes are crucial for understanding treatment effectiveness in routine care.

Purpose of the Study:

• To assess patient-reported treatment effects of low-dose amitriptyline on sleep maintenance in insomnia disorder.
• To evaluate side effects associated with low-dose amitriptyline in a real-world clinical setting.
• To analyze patient satisfaction with amitriptyline treatment for insomnia.

Main Methods:

• A cross-sectional study involving 752 patients with insomnia disorder and sleep maintenance problems.
• Patients self-titrated low-dose amitriptyline (10-20 mg) in an outpatient sleep clinic.
• An online questionnaire assessed sleep, fatigue, satisfaction, and side effects approximately 6 weeks post-treatment initiation.

Main Results:

• 73.9% of patients reported improved sleep maintenance; 31.3% noted improved sleep onset.
• 45.8% were satisfied with treatment outcomes, and 66.1% reported at least one side effect.
• Reported side effects were consistent with known amitriptyline adverse events.

Conclusions:

• Patient-reported outcomes suggest low-dose amitriptyline effectively improves short-term sleep maintenance in insomnia disorder.
• The treatment is generally well-tolerated, supporting its clinical use.
• Results advocate for randomized controlled trials to confirm efficacy and safety in the long term.